Gastrointestinal Infections

During July–September 2023 the role of irrigation water in City A's E coli outbreak.

Trial analyses presented at MAD-ID, The Antimicrobial Stewardship Meeting, highlight the battle against recurrent health care-associated infections (HAI).

Despite no reported cases of illness associated with the affected products, all retailers who received these items have been duly informed, and the recall is being conducted in coordination with the FDA.

Hospital grades released by Leapfrog reviews state and now metro areas for safety and patient satisfaction.

Detection of E coli bacteria and inorganic arsenic in these products raises significant health concerns.

The Food and Drug Administration (FDA) in collaboration with the Centers for Disease Control and Prevention (CDC) and state and local health partners, are investigating a multistate outbreak of E coli O157:H7 infections linked to organic walnuts.

FDA recalls, allergy alerts, e coli & salmonella outbreaks, and more.

US Department of Agriculture’s Food Safety and Inspection Service (FSIS) issued a public health alert over the meat.

Trader Joe’s pulls contaminated organic basil after multi-state illnesses were reported.

Hospitals grapple with the costly burden of healthcare-associated infections (HAIs), and artificial intelligence (AI) is emerging as a game-changer in revolutionizing infection prevention strategies.

FDA notified of allergen threat by New Haven food manufacturer due to mislabeled products.

Officials announce an end of Listeria traced to Rizo-López dairy products involving queso fresco and cotija.

B virus case involves a man who had contact with wild monkeys, FDA approves therapy for teens living with HIV, FDA grants EUA for Flu A/B and COVID at-home testing, and more this week from Contagion.

A study on Italian vaccination rates and factors influencing Rotavirus vaccine acceptance.

FDA approves Zevtera a new treatment option for bacterial infections, a comprehensive look at coccidioidomycosis, the impact of guidelines on reducing hospital-onset CDI incidence, and more this week from Contagion.

Latest discoveries around HpaA's implications for immune response and disease progression.

CDC on enhancing strategies against drinking water diseases.

A team developed and validated a new analytic method to quantify omadacycline and its epimerization in stool to facilitate microbiome research.

The American Gastroenterological Association guidelines navigating fecal microbiota transplantation in clinical practice.

Norovirus cases rise in the northeast and are spreading across the nation.

It affects a limited number of Dole-branded and private label salad kits, and no cases of illness associated with the Dole recall have been reported.

The outbreak has seen 2 deaths and 23 hospitalizations across 11 states.

CDC's use of it and power law analysis have greatly enhanced the detection and understanding of US foodborne outbreaks.

Study shows both recent and earlier use of these medications significantly heightens the risk.

A retrospective cohort study of inpatient encounters from 3 hospitals in the Duke University Health System showed greater rates of testing among White patients compared to Black and NWNB patients.

Participants given omadacycline had high fecal concentrations with a distinct microbiome profile compared to those in the vancomycin group, with study results calling attention to the importance of antibiotics’ impact on the gut microbiome.

Recall affects several raw bulk products sent to restaurants and institutional users, and are marked either angus ground beef patties, ground beef patties, or ground beef.

Over 675,000 cans of specialty infant formula for cow’s milk allergy have been voluntarily recalled by Reckitt/Mead Johnson Nutrition because of a possible contamination with Cronobacter sakazakii.

The 2 recalls were performed due to concerns about salmonella in the former and lead in the latter.

In the news this week, the FDA approved the antifungal, isavuconazonium sulfate, which is indicated for children as young as 1 year of age; the continued clinical usefulness of doxycycline; examining infectious disease consults in gram-negative bacteremia; and a clinician utilizes mobile clinics to bring care to marginalized populations.